UPDATED Nov 27, 2023
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
TDOCTeladoc Health | US$17.21 | -1.5% | -35.0% | US$2.9b | US$22.80 | PS1.1x | E114.5% | n/a | ||
IRTCiRhythm Technologies | US$88.29 | 5.6% | -17.0% | US$2.7b | US$113.30 | PS5.7x | E54.6% | n/a | ||
GDRXGoodRx Holdings | US$5.82 | 1.0% | 30.5% | US$2.4b | US$6.72 | PE157.3x | E50.1% | n/a | ||
NUVANuVasive | US$39.75 | 1.5% | -8.3% | US$2.1b | US$49.00 | PE73.3x | E46.2% | n/a | ||
ICUIICU Medical | US$84.39 | -2.2% | -45.7% | US$2.1b | US$153.50 | PB1x | E68.0% | n/a | ||
STAASTAAR Surgical | US$31.80 | -8.5% | -46.0% | US$1.7b | US$47.75 | PE79.8x | E31.5% | n/a | ||
TVTYTivity Health | US$32.50 | 0.4% | 22.2% | US$1.6b | US$30.17 | PE18.4x | E12.5% | n/a | ||
OMCLOmnicell | US$34.51 | 4.6% | -29.0% | US$1.5b | US$39.33 | PS1.3x | E122.7% | n/a | ||
VIVOMeridian Bioscience | US$33.97 | 0.06% | 54.3% | US$1.5b | US$34.00 | PE35.2x | n/a | 0% | ||
OMIOwens & Minor | US$19.40 | 2.1% | 1.2% | US$1.4b | US$19.40 | PB1.7x | E127.9% | 0% | ||
ADUSAddus HomeCare | US$89.01 | 1.5% | -17.7% | US$1.4b | US$111.33 | PE24.7x | E13.4% | n/a | ||
MDRXVeradigm | US$12.05 | -3.6% | -33.6% | US$1.4b | US$18.40 | PE11.4x | E-40.3% | n/a | ||
UFPTUFP Technologies | US$169.37 | 0.7% | 45.2% | US$1.3b | US$188.00 | PE31x | E14.4% | n/a | ||
SRDXSurmodics | US$33.73 | -3.4% | -2.8% | US$479.3m | US$58.50 | PS3.6x | E-21.4% | n/a | ||
UTMDUtah Medical Products | US$83.62 | -0.4% | -5.4% | US$300.8m | n/a | PE18x | n/a | 1.4% | ||
SMLRSemler Scientific | US$38.36 | 3.9% | 33.5% | US$261.3m | US$65.00 | PE13.2x | E26.2% | n/a | ||
CLPTClearPoint Neuro | US$5.70 | -2.1% | -35.9% | US$148.5m | US$9.50 | PS6.3x | E8.1% | n/a | ||
DRIODarioHealth | US$1.07 | -6.1% | -78.1% | US$29.1m | US$4.70 | PS1.2x | E15.1% | n/a | ||
RHERegional Health Properties | US$1.71 | 1.8% | -36.2% | US$2.9m | n/a | PE0.09x | n/a | 0% |